Castlight Health (CSLT) Was Upgraded by Cantor Fitzgerald to Overweight; Price T Rowe Associates Decreased Its Randgold Res LTD (GOLD) Holding

January 31, 2018 - By Darrin Black

Among 13 analysts covering Castlight Health (NYSE:CSLT), 6 have Buy rating, 1 Sell and 6 Hold. Therefore 46% are positive. Castlight Health has $8 highest and $3.50 lowest target. $4.97’s average target is 44.06% above currents $3.45 stock price. Castlight Health had 29 analyst reports since October 9, 2015 according to SRatingsIntel. As per Tuesday, October 10, the company rating was upgraded by Canaccord Genuity. The firm earned “Hold” rating on Monday, November 6 by Cantor Fitzgerald. The company was maintained on Thursday, August 3 by Canaccord Genuity. Morgan Stanley downgraded Castlight Health, Inc. (NYSE:CSLT) on Friday, May 12 to “Underweight” rating. The stock has “Mkt Perform” rating by FBR Capital on Wednesday, May 11. The company was maintained on Monday, July 10 by Stifel Nicolaus. FBR Capital initiated Castlight Health, Inc. (NYSE:CSLT) rating on Wednesday, November 18. FBR Capital has “Mkt Perform” rating and $5 target. The rating was maintained by Topeka Capital Markets with “Buy” on Thursday, February 18. The stock of Castlight Health, Inc. (NYSE:CSLT) has “Buy” rating given on Wednesday, May 10 by Dougherty & Company. The rating was maintained by Stifel Nicolaus on Thursday, October 26 with “Buy”.

Price T Rowe Associates Inc decreased Randgold Res Ltd (GOLD) stake by 4.34% reported in 2017Q3 SEC filing. Price T Rowe Associates Inc sold 5,570 shares as Randgold Res Ltd (GOLD)’s stock rose 4.27%. The Price T Rowe Associates Inc holds 122,856 shares with $12.00M value, down from 128,426 last quarter. Randgold Res Ltd now has $8.82 billion valuation. The stock increased 0.38% or $0.38 during the last trading session, reaching $101.09. About 588,377 shares traded or 31.05% up from the average. Randgold Resources Limited (NASDAQ:GOLD) has risen 7.63% since January 31, 2017 and is uptrending. It has underperformed by 9.07% the S&P500.

Since August 8, 2017, it had 0 insider buys, and 9 sales for $691,365 activity. Shares for $128,555 were sold by DOYLE JOHN C. On Wednesday, August 16 the insider Colella Giovanni M. sold $29,705. $104,920 worth of Castlight Health, Inc. (NYSE:CSLT) shares were sold by Nolan Mangini Siobhan.

Analysts await Castlight Health, Inc. (NYSE:CSLT) to report earnings on February, 21. They expect $-0.10 earnings per share, down 42.86% or $0.03 from last year’s $-0.07 per share. After $-0.09 actual earnings per share reported by Castlight Health, Inc. for the previous quarter, Wall Street now forecasts 11.11% negative EPS growth.

Investors sentiment increased to 2.05 in 2017 Q3. Its up 0.36, from 1.69 in 2017Q2. It increased, as 5 investors sold Castlight Health, Inc. shares while 15 reduced holdings. 11 funds opened positions while 30 raised stakes. 44.86 million shares or 5.99% more from 42.32 million shares in 2017Q2 were reported. Raymond James Associate reported 0% of its portfolio in Castlight Health, Inc. (NYSE:CSLT). Alliancebernstein Ltd Partnership stated it has 92,750 shares or 0% of all its holdings. Sfmg Limited Liability Co accumulated 10,000 shares or 0.01% of the stock. California Pub Employees Retirement System invested 0% in Castlight Health, Inc. (NYSE:CSLT). Wellcome Ltd (The) As Trustee Of The Wellcome reported 0.45% in Castlight Health, Inc. (NYSE:CSLT). Needham Investment Management Ltd Liability Corporation stated it has 110,000 shares or 0.12% of all its holdings. Stifel Financial Corp invested in 0% or 41,000 shares. State Street has 0% invested in Castlight Health, Inc. (NYSE:CSLT). Advisory Network Lc invested in 2,188 shares. Ny State Common Retirement Fund, a New York-based fund reported 49,600 shares. Moreover, Redmile Grp Limited Liability Corporation has 0% invested in Castlight Health, Inc. (NYSE:CSLT). 507,313 are held by Geode Cap Ltd Limited Liability Company. Jaffetilchin Inv Prns Lc reported 102,888 shares. Gmt Cap owns 703,487 shares or 0.06% of their US portfolio. Manufacturers Life Insurance The reported 55,689 shares.

The stock decreased 6.76% or $0.25 during the last trading session, reaching $3.45. About 514,568 shares traded or 49.09% up from the average. Castlight Health, Inc. (NYSE:CSLT) has declined 18.00% since January 31, 2017 and is downtrending. It has underperformed by 34.70% the S&P500.

Castlight Health, Inc. operates a health benefits platform in the United States. The company has market cap of $461.39 million. The company's platform engages employees to make better health decisions and enables employers to communicate and measure their benefit programs. It currently has negative earnings. The Company’s platform also provides real-time insight into employee engagement with benefits and programs enabling employers to monitor and adjust their strategies.

Analysts await Randgold Resources Limited (NASDAQ:GOLD) to report earnings on February, 5. They expect $0.81 EPS, down 2.41% or $0.02 from last year’s $0.83 per share. GOLD’s profit will be $70.63 million for 31.20 P/E if the $0.81 EPS becomes a reality. After $0.51 actual EPS reported by Randgold Resources Limited for the previous quarter, Wall Street now forecasts 58.82% EPS growth.

Price T Rowe Associates Inc increased Bofi Hldg Inc (NASDAQ:BOFI) stake by 21,600 shares to 58,575 valued at $1.67M in 2017Q3. It also upped Equifax Inc (NYSE:EFX) stake by 440,988 shares and now owns 14.64 million shares. Vulcan Matls Co (NYSE:VMC) was raised too.

Among 15 analysts covering Randgold-Resources (NASDAQ:GOLD), 10 have Buy rating, 0 Sell and 5 Hold. Therefore 67% are positive. Randgold-Resources had 31 analyst reports since July 24, 2015 according to SRatingsIntel. The company was downgraded on Monday, April 18 by Citigroup. The company was upgraded on Friday, September 9 by UBS. Jefferies upgraded Randgold Resources Limited (NASDAQ:GOLD) on Thursday, July 14 to “Buy” rating. RBC Capital Markets downgraded the stock to “Sector Perform” rating in Wednesday, February 24 report. The firm has “Buy” rating given on Friday, July 24 by Citigroup. BMO Capital Markets downgraded Randgold Resources Limited (NASDAQ:GOLD) on Monday, March 14 to “Market Perform” rating. The firm has “Buy” rating given on Monday, June 27 by Goldman Sachs. The firm has “Add” rating given on Monday, August 10 by Numis Securities. As per Friday, July 1, the company rating was upgraded by Macquarie Research. The firm has “Neutral” rating given on Monday, September 14 by JP Morgan.